These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17083019)

  • 21. Serious infection associated with induced abortion in the United States.
    Dempsey A
    Clin Obstet Gynecol; 2012 Dec; 55(4):888-92. PubMed ID: 23090457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mifepristone and misoprostol sequential regimen side effects, complications and safety.
    Sitruk-Ware R
    Contraception; 2006 Jul; 74(1):48-55. PubMed ID: 16781261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Septic shock after medical abortions with mifepristone (Mifeprex, RU 486) and misoprostol.
    Murray S; Wooltorton E
    CMAJ; 2005 Aug; 173(5):485. PubMed ID: 16093445
    [No Abstract]   [Full Text] [Related]  

  • 24. Positive Clostridium difficile stool assay in a patient with fatal C. sordellii infection.
    Elsayed S; Zhang K
    N Engl J Med; 2006 Sep; 355(12):1284-5. PubMed ID: 16990397
    [No Abstract]   [Full Text] [Related]  

  • 25. Toxic shock syndrome due to Clostridium sordellii: a dramatic postpartum and postabortion disease.
    Sinave C; Le Templier G; Blouin D; Léveillé F; Deland E
    Clin Infect Dis; 2002 Dec; 35(11):1441-3. PubMed ID: 12439811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deaths associated with medication abortion.
    Darney PD
    Contraception; 2005 Oct; 72(4):319. PubMed ID: 16181979
    [No Abstract]   [Full Text] [Related]  

  • 27. Vaginal vs. sublingual misoprostol with mifepristone for cervical priming in second-trimester abortion by dilation and evacuation: a randomized clinical trial.
    Carbonell JL; Gallego FG; Llorente MP; Bermudez SB; Sala ES; González LV; Texido CS
    Contraception; 2007 Mar; 75(3):230-7. PubMed ID: 17303495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Möbius syndrome in a neonate after mifepristone and misoprostol elective abortion failure.
    Bos-Thompson MA; Hillaire-Buys D; Roux C; Faillie JL; Amram D
    Ann Pharmacother; 2008 Jun; 42(6):888-92. PubMed ID: 18460590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clostridium sordellii infection: epidemiology, clinical findings, and current perspectives on diagnosis and treatment.
    Aldape MJ; Bryant AE; Stevens DL
    Clin Infect Dis; 2006 Dec; 43(11):1436-46. PubMed ID: 17083018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comment on "Misoprostol impairs female reproductive tract innate immunity against Clostridium sordellii".
    Shannon C; Winikoff B
    J Immunol; 2008 Aug; 181(4):2263; author reply 2263-4. PubMed ID: 18684913
    [No Abstract]   [Full Text] [Related]  

  • 31. Misoprostol impairs female reproductive tract innate immunity against Clostridium sordellii.
    Aronoff DM; Hao Y; Chung J; Coleman N; Lewis C; Peres CM; Serezani CH; Chen GH; Flamand N; Brock TG; Peters-Golden M
    J Immunol; 2008 Jun; 180(12):8222-30. PubMed ID: 18523288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Misoprostol and pregnancy: risk of malformations.
    Prescrire Int; 2008 Apr; 17(94):65-6. PubMed ID: 18516817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized trial to compare two dosing intervals of misoprostol following mifepristone administration in second trimester medical abortion.
    Chai J; Tang OS; Hong QQ; Chen QF; Cheng LN; Ng E; Ho PC
    Hum Reprod; 2009 Feb; 24(2):320-4. PubMed ID: 19049993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infections caused by Clostridium perfringens and Paeniclostridium sordellii after unsafe abortion.
    Aronoff DM; Marrazzo JM
    Lancet Infect Dis; 2023 Feb; 23(2):e48-e55. PubMed ID: 36155670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial.
    von Hertzen H; Piaggio G; Wojdyla D; Marions L; My Huong NT; Tang OS; Fang AH; Wu SC; Kalmar L; Mittal S; Erdenetungalag R; Horga M; Pretnar-Darovec A; Kapamadzija A; Dickson K; Anh ND; Tai NV; Tuyet HT; Peregoudov A;
    BJOG; 2009 Feb; 116(3):381-9. PubMed ID: 19187370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two-pill regimens of misoprostol after mifepristone medical abortion through 63 days' gestational age: a randomized controlled trial of sublingual and oral misoprostol.
    Raghavan S; Comendant R; Digol I; Ungureanu S; Friptu V; Bracken H; Winikoff B
    Contraception; 2009 Feb; 79(2):84-90. PubMed ID: 19135563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complications after second trimester surgical and medical abortion.
    Grossman D; Blanchard K; Blumenthal P
    Reprod Health Matters; 2008 May; 16(31 Suppl):173-82. PubMed ID: 18772098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medical management of early pregnancy failure: efficacy.
    Chen BA; Creinin MD
    Semin Reprod Med; 2008 Sep; 26(5):411-22. PubMed ID: 18825609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Foot infection by Clostridium sordellii: case report and review of 15 cases in France.
    Bouvet P; Sautereau J; Le Coustumier A; Mory F; Bouchier C; Popoff MR
    J Clin Microbiol; 2015 Apr; 53(4):1423-7. PubMed ID: 25609723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
    Guest J; Chien PF; Thomson MA; Kosseim ML
    BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.